{Ginevra} Second Stem Cell Therapy for ONH/ SOD | Stem Cell Treatment Testimonial
It's Ginevra's second stem cell treatment for Optic Nerve Hypoplasia/Septo Optic Dysplasia. After the first treatment, she experienced significant improvements in her visual and motor conditions over three months. Previously unable to perceive light, Ginevra can now follow it and has started to walk. According to her family, Beike's treatment—which included four lumbar and four intravenous injections supplemented with growth factor for nerve growth—was administered smoothly and with minimal pain by a professional nursing team. During the first round, Ginevra began to distinguish colors and take her first steps. The expectation for the second treatment is further improvements in distance vision and object perception. Watch the full video to hear her family's insights.
Improvement statistics
Based on follow-up reports from 115 patients across 276 forms, here is the percentage who self-reported any improvement after treatment.
About this data
Patients self-assess each symptom on a 5-point scale (Worse / No improvement / Small / Moderate / Significant) at follow-up checkpoints after treatment, comparing to their pre-treatment baseline. "Reported improvement" combines the small, moderate and significant buckets. Data is updated daily from our internal patient registry. As with any medical treatment, past results do not guarantee future outcomes — improvements vary from patient to patient.
